Milestone Pharmaceuticals Inc (MIST NASDAQ) stock market data APIs
$1.3791
-0.12(-8.7%)
as of April 2, 2026
Try our APIs with
free plan!
Milestone Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Prev. Close
1.3791
Open
1.2571
High
1.4007
Low
1.2407
52 wk Range
0.625-3.06
Market Cap
154 M
Shares Outstanding
118 M
Revenue
1 546 K
EPS
-0.15
Beta
0.541
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Milestone Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Milestone Pharmaceuticals Inc data using free add-ons & libraries
Get Milestone Pharmaceuticals Inc Fundamental Data
Milestone Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 1 546 K
- EBITDA: -62 026 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-03-31
- EPS/Forecast: -0.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Milestone Pharmaceuticals Inc News
New
Etripamil Drives Milestone Pharma's Q4 Revenue; Eyes EMA Marketing Approval In H1,2027; Stock Up
(RTTNews) - Milestone Pharmaceuticals Inc. (MIST), a commercial-stage biopharmaceutical company, reported fourth-quarter and full-year 2025 results and provided corporate updates for its lead product,...
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize CARDAMYST™ (Etripamil) Nasal Spray in Greater China
SHANGHAI, March 23, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and ...
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT
FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in clinical studies were 2x more likely to convert sympto...
Here are the major earnings before the open Friday
Major earnings expected before the bell on Friday include: * Milestone Pharmaceuticals (MIST [https://seekingalpha.com/symbol/MIST]) * Westwater Resources (WWR [https://seekingalpha.com/symbol/WW...
Get Milestone Pharmaceuticals Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
